Autologous bone marrow stem cell therapy
Commercial- Indications
- Osteoarthritis, Joint pain, Back pain, Neck pain, PTSD, Neuropathy, COPD
Company intelligence / Profile preview
The center offers FDA-compliant autologous bone marrow-derived stem cell therapies ("Gold Standard Stem Cell Therapy™") for orthopedic conditions with an emphasis on safety and efficacy. They use registry-based protocols with minimum viable nucleated cell counts. Clinical results are described as “proven” based on patient registry data but no formal clinical trial data published. Additional offerings include platelet-rich plasma injections and various non-stem-cell-based aesthetic/cosmetic procedures. No investigational new drugs or regulatory submissions typical of biotech/pharma companies. Dr. Charles Lee leads the center with advanced training in regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Regenesis Stem Cell Center.